ERCP及PTC設備(一般外科)-全球市場分析及預測模式(COVID-19對市場造成的影響)

本報告詳細探討2020年及以後的COVID-19對ERCP和PTC器件市場的影響。ERCP和PTC設備通常用於治療由良性或惡性原因引起的阻塞性黃疸，以及膽道滲漏的管理。這些裝置還用於預防胰腺炎和排泄膽囊和胰腺液。

這些設備通過兩個主要步驟放置：內窺鏡逆行胰膽管造影（ERCP）和經皮經肝膽管造影（PTC）。ERCP內窺鏡還用於從膽管中清除膽結石，擴張狹窄部位或將支架放置在阻塞的導管中以保持膽囊打開，而無需手術。撐開導管可立即緩解惡性阻塞，例如胰腺癌。

本報告提供ERCP及PTC設備市場相關調查，提供市場概要，以及2015∼2030年的市場預測，各市場區隔，各國的趨勢等資訊。

• 主要的產業趨勢洞察
• 2015年∼2030年各分類市場預測
• 手術數量，台數，平均銷售價格，各分類市場價值相關詳細資料

全球地區，各國趨勢

• 各國分析
• SWOT分析
• 競爭趨勢

健康護理系統概要

• 醫療保健制度的各國概要
• 各國給付方針
• 國家固有的醫療技術相關法規趨勢

網羅的企業:Boston Scientific Corp, ConMed Corp, Cook Group Inc, Olympus Corp, Merit Medical Systems Inc，其他

觀察對象國家:美國，英國，德國，法國，義大利，西班牙，巴西，中國，印度，俄羅斯，日本，澳洲，加拿大，墨西哥，韓國，丹麥，愛爾蘭，荷蘭，紐西蘭，南非，瑞典，瑞士，奧地利，比利時，芬蘭，以色列，挪威，波蘭葡萄牙，台灣，捷克，希臘，匈牙利，土耳其，埃及，沙烏地阿拉伯，阿拉伯聯合大公國，阿根廷，智利

ERCP and PTC Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area.

The model discusses in detail the impact of COVID-19 on ERCP & PTC Devices market for the year 2020 and beyond. ERCP and PTC devices are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These devices are also used for preventing pancreatitis and to drain the gallbladder and pancreatic fluids.

These devices are placed through two major procedures: Endoscopic Retrograde Cholangio -Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC). ERCP endoscopes are also used for the removal of gallstones from the bile ducts, dilating strictures, or placing stents in blocked ducts to hold them open, all without surgery. Stenting a duct may give immediate relief of a malignant obstruction such as pancreatic cancer.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ERCP & PTC Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total ERCP & PTC Devices market revenue by segment and market outlooks from 2015-2030.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for ERCP & PTC Devices market.
• Competitive dynamics insights and trends provided for ERCP & PTC Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Boston Scientific Corp, ConMed Corp, Cook Group Inc, Olympus Corp, Merit Medical Systems Inc, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the ERCP & PTC Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on ERCP & PTC Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving ERCP & PTC Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ERCP & PTC Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific ERCP & PTC Devices from 2015-2030.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.